Clinical Trial Update: Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the effects of moxonidine and diet on sympathetic function in young adults with obesity. The sponsor is Baker Heart an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Moxonidine (moxonidine)

Snippet

Sponsor: Baker Heart and Diabetes Institute | Conditions: Obesity, Overweight | Phase 4 | Status: UNKNOWN